The findings summarized in this review may contributeto the rational structure-guided development of therapeutic vaccines,novel diagnostic tools for early cancer detection, and new cancertreatments for cancer with tailored anti-Tn or anti-STn antibodiesor new drugs to inhibit GalNAc-T isoenzymes. This evidence concerns the gene EEF1A2 and cancer.